Q-omics provides the consensus-scored ULK4P1 profile across patient tissues and cancer cell-line models. ULK4P1 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, ULK4P1 is differentially expressed in 6, with the highest sampling consensus in THCA. Additionally, ULK4P1 RNA expression shows 7,292 significant gene co-expression associations, with the highest sampling consensus in SARC. Together, these results highlight UCS, THCA, and SARC as cancer lineages where ULK4P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ULK4P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ULK4P1 survival associations across molecular data types. ULK4P1 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ULK4P1 RNA expression–survival associations across cancer types. High ULK4P1 expression shows unfavorable associations in UCEC and KICH, but favorable associations in UCS, UVM, COAD and LIHC. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .003). Together, the overview and detailed table identify UCS as the clearest survival context for ULK4P1 RNA expression.
This table summarizes ULK4P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for ULK4P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ULK4P1 shows lower tumor expression in THCA, BRCA, READ and LUSC and higher tumor expression in LUSC and KIRP. The THCA box plot shows higher ULK4P1 RNA expression in normal versus tumor tissue (log2 FC = −0.093, t-test p < 0.001).
This table shows molecular features associated with ULK4P1 in patient tissues and cancer cell lines. In patient samples, ULK4P1 shows the broadest associations at the RNA and protein expression levels, with SARC recurring as the lineage with the largest associated feature set.
